Thompson Davis & CO. Inc. Raises Position in Johnson & Johnson $JNJ

Thompson Davis & CO. Inc. boosted its holdings in Johnson & Johnson (NYSE:JNJ) by 332.7% during the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 10,749 shares of the company’s stock after acquiring an additional 8,265 shares during the quarter. Johnson & Johnson accounts for about 0.7% of Thompson Davis & CO. Inc.’s investment portfolio, making the stock its 20th largest position. Thompson Davis & CO. Inc.’s holdings in Johnson & Johnson were worth $1,642,000 as of its most recent SEC filing.

A number of other large investors have also recently modified their holdings of JNJ. GFG Capital LLC purchased a new position in Johnson & Johnson in the 2nd quarter worth approximately $35,000. Stone House Investment Management LLC purchased a new stake in shares of Johnson & Johnson during the 1st quarter valued at $47,000. 1248 Management LLC bought a new stake in shares of Johnson & Johnson during the 1st quarter worth $48,000. Harvest Fund Management Co. Ltd purchased a new position in Johnson & Johnson in the first quarter worth $52,000. Finally, Pandora Wealth Inc. bought a new position in Johnson & Johnson in the first quarter valued at $65,000. Institutional investors own 69.55% of the company’s stock.

Analysts Set New Price Targets

Several brokerages have issued reports on JNJ. Daiwa America raised Johnson & Johnson from a “hold” rating to a “strong-buy” rating in a research note on Monday, October 20th. Wall Street Zen raised Johnson & Johnson from a “hold” rating to a “buy” rating in a research note on Saturday, September 13th. Argus set a $210.00 price target on shares of Johnson & Johnson in a research note on Wednesday, October 15th. Weiss Ratings reiterated a “buy (b)” rating on shares of Johnson & Johnson in a report on Friday, October 31st. Finally, JPMorgan Chase & Co. increased their target price on Johnson & Johnson from $185.00 to $200.00 and gave the company a “neutral” rating in a report on Tuesday, September 16th. Three investment analysts have rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and nine have assigned a Hold rating to the company. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $199.05.

Insider Transactions at Johnson & Johnson

In other Johnson & Johnson news, EVP Jennifer L. Taubert sold 56,471 shares of the firm’s stock in a transaction on Thursday, September 4th. The stock was sold at an average price of $177.81, for a total transaction of $10,041,108.51. Following the completion of the transaction, the executive vice president owned 178,013 shares of the company’s stock, valued at approximately $31,652,491.53. This trade represents a 24.08% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Company insiders own 0.16% of the company’s stock.

Johnson & Johnson Trading Down 0.1%

NYSE JNJ opened at $194.12 on Thursday. The stock has a market cap of $467.69 billion, a P/E ratio of 18.69, a price-to-earnings-growth ratio of 2.19 and a beta of 0.38. Johnson & Johnson has a fifty-two week low of $140.68 and a fifty-two week high of $195.54. The stock has a 50 day simple moving average of $185.13 and a two-hundred day simple moving average of $169.48. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.80 and a current ratio of 1.07.

Johnson & Johnson (NYSE:JNJ) last announced its earnings results on Wednesday, August 30th. The company reported $2.26 EPS for the quarter. Johnson & Johnson had a return on equity of 32.73% and a net margin of 27.26%.The company had revenue of $24.02 billion during the quarter. On average, analysts forecast that Johnson & Johnson will post 10.58 earnings per share for the current year.

Johnson & Johnson Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 9th. Shareholders of record on Tuesday, November 25th will be issued a dividend of $1.30 per share. The ex-dividend date is Tuesday, November 25th. This represents a $5.20 dividend on an annualized basis and a dividend yield of 2.7%. Johnson & Johnson’s dividend payout ratio is 50.19%.

About Johnson & Johnson

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension.